Rep. Gottheimer Honors Rare Disease Week, Speaks With 'The Hill' About Research and Development for New Cures
February 25, 2022
February 25, 2022
WASHINGTON, Feb. 25 -- Rep. Josh Gottheimer, D-New Jersey, issued the following news release:
To recognize Rare Disease Week, U.S. Congressman Josh Gottheimer (NJ-5) spoke at The Hill's COVID-19 & Rare Disease Patients event to discuss what can be done to help us invest more in research and development for cures for orphan or rare diseases, which currently have no FDA-approved treatments.
Gottheimer highlighted his bipartisan legislation -- Cameron's Law - . . .
To recognize Rare Disease Week, U.S. Congressman Josh Gottheimer (NJ-5) spoke at The Hill's COVID-19 & Rare Disease Patients event to discuss what can be done to help us invest more in research and development for cures for orphan or rare diseases, which currently have no FDA-approved treatments.
Gottheimer highlighted his bipartisan legislation -- Cameron's Law - . . .